Pharmaceutical formulations and methods of use which combine non-steroidal anti-inflammatory compounds with antihypertensive compounds
AssigneeKitov Pharmaceuticals Ltd.
InventorsPeter C. Hoyle, Paul Waymack
Life of this patent
Estimating the term…
Abstract
An oral dosage form of a non-steroidal anti-inflammatory drug (NSAID) is rendered safer for extended or chronic use for anti-inflammatory, analgesic or antipyretic therapy by combining it with an antihypertensive drug. The antihypertensive drug acts prophylactically to inhibit or reduce NSAID-induced hypertension and by so doing the adverse cardiovascular side effects of NSAIDs, such as high blood pressure, heart attack, stroke, opththamologic complications, and death, when NSAIDs are used repetitively over an extended period of time for reducing inflammation or in pain management.
Claims2
1-14. (canceled)
A method for ameliorating celecoxib-induced elevation of blood in a subject, comprising:
- providing to a subject at least one dose comprising a combination of celecoxib and a calcium channel blocker,
- wherein the amount of celecoxib is sufficient to cause elevation in blood pressure, and
- wherein the amount of calcium channel blocker is sufficient to ameliorate blood pressure elevation.
Dependencies are inferred from the claim text.